ASX Announcements

Title Date
Preliminary Final Report31-08-2010
Amended Appendix 3B Rights Issue 31-08-2010
Renounceable Issue Prospectus29-08-2010
Renounceable Issue Shareholder Letter 29-08-2010
Renounceable Issue Optionholder Letter 29-08-2010
Rights Issue prelim Appendix 3B26-08-2010
Fully Underwritten Renouncable Rights Issue26-08-2010
US analyst values Phylogica at significant premium to market22-08-2010
Bioshares CEO Interview P Watt19-08-2010
Finance News Network Interview with Director Nick Woolf19-08-2010
Alliance with AstraZeneca to discover new antimicrobials18-08-2010
Reinstatement of Official Quotation17-08-2010
Agreement Update16-08-2010
Response to ASX Query - Appendix 4C08-08-2010
Suspension from Official Quotation 04-08-2010
‹ First  < 1 2 3 4 5 > 
© 2012 Phylogica    |    ABN 48 098 391 961    |    Privacy Statement
Last updated: 02-02-2012    |    Website by Harmonic New Media and College Hill Life Sciences